a study comparing the effect of metronidazol and tinidazol in treating Bacterial vaginosis (BV)

a randomized, double blind, comparative study of oral metronidazole and tinidazole in treatment of bacterial vaginosis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/04/004557

Enrollment

120

Registered

2014-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N760- Acute vaginitis Health Condition 2: null- bacterial vaginosis

Interventions

Intervention1: tinidazol: tablet tinidazol- 500mg once daily for 5days Control Intervention1: metronidazol: tab metronidazol 500mg twice daily for 5days

Eligibility

Inclusion criteria

Inclusion criteria: women diagnosed with bacterial vaginosis

Exclusion criteria

Exclusion criteria: pregnant and lactating mothers, history of smoking and alcohol, previous history of bactrial vaginosis, with STDs, HIV or genital malignancies, antimicrobial use in previous 14 days

Design outcomes

Primary

Measure	Time frame
compare the cure rate of oral metronidazol with tinidazolTimepoint: compare the cure rate at the end of 5 days of oral metronidazol with tinidazol	—

Secondary

Measure	Time frame
compare adverse effects of metronidazol with tinidazolTimepoint: 5days	—

Countries

India

Contacts

Public ContactDr Indu M raja

Sri Venkateshwara Medical College Hospital and research center

anildipali@yahoo.co.in9442359900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026